Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02505022 · ClinicalTrials.gov registry record
Role Functioning Changes NOS
A clinical trial, sponsored by Northwestern University.
- Terminated
- Registry status
- 28
- Enrollment target
NCT02505022: Clinical Trial study, sponsored by Northwestern University.
NCT02505022 is a clinical trial that was terminated before completion, run by Northwestern University. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02505022 was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- 28 participants
- Enrollment target
Study Summary
During this study the investigators will 1) collect measures of social cognition and social functioning in adolescents and young adults who are experiencing early symptoms of a major mental disorder; and 2) evaluate the predictive value and utility of a new role functioning assessment measure for individuals experiencing changes in their lives after an index episode of mental illness. This will happen in the context of providing treatment-as-usual to individuals who arrive seeking help with the early phases of mental illness.
Interventions
- DRUG Pharmacotherapy
- BEHAVIORAL Behavioral treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2016-01 |
| Est. Completion | 2021-01 |
Why NCT02505022 stopped before completion
NCT02505022 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Pharmacotherapy is the first listed.
NCT02505022 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02505022 about?
NCT02505022 is a clinical study titled "Role Functioning Changes NOS". During this study the investigators will 1) collect measures of social cognition and social functioning in adolescents and young adults who are experiencing early symptoms of a major mental disorder; and 2) evaluate the predictive value and utility of a new role functioning assessment measure for in...
What is the current status of trial NCT02505022?
This trial is currently terminated. The enrollment target is 28 participants. The study started on 2016-01. Estimated completion is 2021-01.
What interventions are being tested in trial NCT02505022?
The interventions under investigation include: Pharmacotherapy (DRUG), Behavioral treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT02505022?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia